Prof. Serkan Erkanlı is Head of the Department of Gynecologic Oncology Surgery at Acıbadem Mehmet Ali Aydınlar University. He holds the 2023 European Gynecological Oncology Certificate (ESGO Professional Recognition), reflecting advanced training and recognition in gynecological oncology. With a clinical focus on surgical management of gynecologic cancers and minimally invasive and robotic techniques, he leads multidisciplinary care and surgical education programs. His responsibilities include directing surgical services, mentoring trainees, and advancing best practices in oncologic gynecology. An active member of national and international professional societies, he contributes to the field through the Turkish Medical Association, the Turkish Society of Gynecologic Oncology (TRSGO), the Cervical Pathologies and Colposcopy Society, the European Society of Gynecological Oncology (ESGO), the International Gynecologic Cancer Society (IGCS), the Turkish Gynecology and Obstetrics Society, the Minimally Invasive Gynecology Society, the Minimally Invasive Gynecologic Oncology Society, and the Robotic Surgery Association. Prof. Erkanlı is committed to improving outcomes for patients with gynecologic cancers through evidence-based surgical care, innovation in minimally invasive and robotic approaches, and training the next generation of specialists.
Education
- 2023 European Gynecological Oncology Certificate – ESGO Professional Recognition in Gynaecological Oncology Certificate Health and Medicine , European Society of Gynecological Oncology – European Society of Gynaecological Oncology “ESGO
- 2011 Board of Medical Specialization Gynecologic Oncology Surgery
- 2011 IRCAD Robotic Surgery Strasbourg, France
- 2007 Başkent University Faculty of Medicine, Department of Obstetrics and Gynecology, Associate Professor
- 2005 Department of Gynecologic Oncology, St. Stephen’s Hospital, Budapest, Hungary, Fellow
- 2003 Centre Oscar Lambret Cancer Center, Lille, France, Fellow
- 2000 – 2001 University of Southern California (USC),Keck School of Medicine Women’s and Children’s Hospital,Department of Gynecologic Oncology,Norris Cancer Institute, Los Angeles, California, USA, Visiting Fellow
- 1999 Marmara University Faculty of Medicine Gynecology and Obstetrics
- 1988 – 1995 Istanbul University Cerrahpasa Faculty of Medicine
- 1981 – 1988 Kadıköy Anatolian High School
Experience
- 2021 Acıbadem Mehmet Ali Aydınlar University / Head of Department of Gynecologic Oncology Surgery
- 2010 Acibadem Health Group
- 2002 – 2010 Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Adana
- 2001 – 2002 Private Bahat Hospital, Istanbul
- 1995 – 1999 Department of Obstetrics and Gynecology, Marmara University Faculty of Medicine, Istanbul, Turkey
Memberships
- Turkish Medical Association
- Turkish Society of Gynecologic Oncology (TRSGO)
- Cervical Pathologies and Colposcopy Society
- European Society of Gynecological Oncology (ESGO)
- International Gynecologic Cancer Society (IGSC)
- Turkish Gynecology and Obstetrics Society
- Minimally Invasive Gynecology Society
- Minimally Invasive Gynecologic Oncology Society
- Robotic Surgery Association
Publications
- Fertility sparing therapy in young women with endometrial cancer: 2010 Update.
Int. J Gynecol. Cancer 20,1170-1187, 2010 Erkanli S., Ayhan A. - Maspin Overexpression Correlates With Increased Expression of Vascular Endothelial Growth factors A, C, and D in Human Ovarian Carcinoma.
Bolat F., Gumurdulu D., Erkanli S., Kayaselcuk F., Zeren H., Vardar MA, Kuscu E. Pathology Research and Practice 204(6):379-87, 2008 - How best is to discontinue postmenopausal hormone therapy: Immediate or tapering?
Aslan E., Bagis T., Kilicdag E.B., Tarim E., Erkanli S., Kuscu E. Maturitas. 56(1),78-83, 2007 - COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma.
Erkanli S. , Bolat F., Kayaselcuk F., Demirhan B., Kuscu E. Gynecol. Oncol. 104(2),320-325, 2007 - Impact of morbid obesity in surgical management of endometrial cancer: surgical morbidity, clinical and pathological aspects.
Erkanli S., Kayaselcuk F., Bagis T., Kuscu E. Eur. J. Gynaecol Oncol. 27(4),401-404, 2006 - Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
Erkanli S., Kayaselcuk F., Kuscu E., Bagis T., Bolat F., Haberal A., Demirhan B. Int. J. Gynecol. Cancer. 16(3),1412-1418, 2006 - Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters.
Kayaselcuk F., Erkanli S., Bolat F., Seydaoglu G., Kuscu E., Demirhan B. Int. J. Gynecol. Cancer. 16(1):402-408, 2006 - Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
Erkanli S., Kayaselcuk F., Kuscu E., Bolat F., Sakalli H., Haberal A. Breast. 15(4),558-561, 2006 - HPV and p53 expression in epithelial ovarian carcinoma.
Kuscu E., Ozdemir B.H., Erkanli S., Haberal A. Eur. J. Gynaecol. Oncol. 26(6),642-645, 2005 - Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Kilicdag E.B., Bagis T., Zeyneloglu H.B., Tarim E., Aslan E., Haydardedeoglu B., Erkanli S. Hum. Reprod. 20(4),894-899, 2005
